Clinical trial
SUBA-itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses: a Multi-center, Open-label Comparative Trial
NCT03572049 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SUBA-itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses: a Multi-center, Open-label Comparative Trial
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 17, 2018
- Completion date
- April 29, 2022
- Enrollment
- 88 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.